154
Participants
Start Date
October 31, 2010
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
Dronedarone
"Pharmaceutical form: tablet~Route of administration: oral (together with meal)~Dose regimen: 400 mg twice daily"
Investigational Site Number 208-003, København S
Investigational Site Number 208-002, Copenhagen
Investigational Site Number 208-001, Aarhus
Investigational Site Number 484002, México
Investigational Site Number 203001, Prague
Investigational Site Number 203004, Prague
Investigational Site Number 484003, Aguascalientes
Investigational Site Number 203008, Příbram
Investigational Site Number 484004, Torreón
Investigational Site Number 203003, Kladno
Investigational Site Number 724002, Madrid
Investigational Site Number 724006, Valdemoro
Investigational Site Number 724003, Málaga
Investigational Site Number 250-006, Toulouse
Investigational Site Number 250-001, Montpellier
Investigational Site Number 250-003, Chambray-lès-Tours
Investigational Site Number 250-002, Grenoble
Investigational Site Number 203007, Prachatice
Investigational Site Number 484006, Zapopan
Investigational Site Number 724004, Barakaldo
Investigational Site Number 276-001, Bonn
Investigational Site Number 276-005, Hagen
Investigational Site Number 484001, San Luis Potosí City
Investigational Site Number 484005, San Luis Potosí City
Investigational Site Number 203006, Sternberk
Investigational Site Number 250-004, Amiens
Investigational Site Number 276-003, Nuremberg
Investigational Site Number 250-005, Boulogne-Billancourt
Investigational Site Number 170001, Bogotá
Investigational Site Number 170002, Bucaramanga
Investigational Site Number 170003, Cartagena
Investigational Site Number 170006, Cartagena
Investigational Site Number 170007, Floridablanca
Investigational Site Number 170005, Medellín
Investigational Site Number 203005, Brno
Investigational Site Number 203002, Olomouc
Investigational Site Number 276-002, Chemnitz
Investigational Site Number 276-004, Wermsdorf
Investigational Site Number 724001, Barcelona
Investigational Site Number 724005, L'Hospitalet de Llobregat
Lead Sponsor
Sanofi
INDUSTRY